The acute course of COVID-19 is variable and ranges from asymptomatic infection to
fulminant respiratory failure. Patients recovering from COVID-19 can have persistent …

Objectives “Long COVID”, a term coined by COVID-19 survivors, describes persistent or new
symptoms in a subset of patients who have recovered from acute illness. Globally, the …

The majority of people infected with SARS-CoV-2 fully recovered within a few weeks.
However, a considerable number of patients of different ages still suffer from long-lasting …

The risk factors for development of fibrotic-like radiographic abnormalities after severe
COVID-19 are incompletely described and the extent to which CT findings correlate with …

Objective Although complications and clinical symptoms of COVID-19 have been elucidated,
the prevalence of long-term sequelae of COVID-19 is less clear in previously hospitalized …

Since the initial identification of the novel coronavirus SARS-CoV-2 in December 2019, the
COVID-19 pandemic has become a leading cause of morbidity and mortality worldwide. As …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) is still increasing
worldwide, and as a result, the number of patients with pulmonary fibrosis secondary to …

Long COVID-19 is a recognized entity that affects millions of people worldwide. Its broad
clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath …

Background Whether prone position (PP) improves clinical outcomes in COVID-19
pneumonia treated with noninvasive ventilation (NIV) is unknown. We evaluated the effect of …

Pulmonary fibrosis (PF), a pathological outcome of chronic and acute interstitial lung
diseases associated to compromised wound healing, is a key component of the “post-acute …